Insulet Corporation, announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH ® Personal Diabetes Managers distributed globally. Insulet received reports from Omnipod DASH ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), announced on October 17, 2022, a Medical Device Correction for all Omnipod DASH® Personal Diabetes Managers (PDMs) distributed ...

By Timothy Doyle Acton medical device manufacturer Insulet Corp. issued a voluntary medical device correction on its Omnipod DASH Personal Diabetes Manager on Oct. 17.

Instead, Dash users must rely on the smartphonelike Personal Diabetes Manager (PDM), which comes free with their first shipment of Dash insulin pods. The touchscreen device connects wirelessly to ...

Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash ...

The Omnipod DASH Insulin Management System is the first and only tubeless device that can provide three days of non-stop insulin delivery1. Its unique design consists of just two parts; a ...

The Omnipod DASH system is anticipated to launch in early 2019. For more information call (800) 591-3455 or visit MyOmniPod.com.

The Omnipod DASH System features a tubeless, waterproof* Pod that provides up to 72 hours of non-stop insulin with an intuitive, colour touch-screen Personal Diabetes Manager that is a locked-down ...

An insulin management system made by Acton medical device company Insulet is now available in Canada, the company announced on Monday. “The Omnipod DASH System’s sleek, touchscreen Personal ...